Literature DB >> 6300668

Sister-chromatid exchange induction by indirect mutagens/carcinogens, aryl hydrocarbon hydroxylase activity and benzo[alpha]pyrene metabolism in cultured human hepatoma cells.

S Abe, N Nemoto, M Sasaki.   

Abstract

2 human hepatoma cell lines (C-HC-4 and C-HC-20), in which aryl hydrocarbon hydroxylase activity was induced with benz[alpha]anthracene in vitro to about 140- and 64-fold of the respective basal levels, yielded an increased frequency of sister-chromatid exchanges (SCEs) when exposed to benzo[alpha]pyrene (BP), 7,12-dimethylbenz[alpha]anthracene and 3-methylcholanthrene in vitro. Analysis of the metabolism of BP by these cells by high-pressure liquid chromatography revealed that both cell lines produced various BP metabolites including the proximate form BP-7,8-dihydrodiol which has been reported to be the most potent inducer of SCEs among the metabolites of BP. In addition, aflatoxin B1 and cyclophosphamide also induced SCEs in these cell lines. The above findings suggest that these cells may be capable of metabolizing a range of indirect mutagens/carcinogens into DNA-active forms. These cells may therefore serve as a useful test system in vitro for the detection of genotoxic agents, without the use of an exogenous activating system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300668     DOI: 10.1016/0027-5107(83)90097-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

1.  Antithrombotic treatment strategy for patients with coronary artery ectasia and acute myocardial infarction: A case report.

Authors:  Rui-Feng Liu; Xiang-Yu Gao; Si-Wen Liang; Hui-Qiang Zhao
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

2.  Benzo(a)pyrene promotes Hep-G2 cell migration and invasion by upregulating phosphorylated extracellular signal-regulated kinase expression.

Authors:  Yadong Wang; Teng Pan; Li Li; Haiyu Wang; Ding Zhang; Haiyan Yang
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.